M&A Deal Summary

IBX Acquires Roylance Pharma

On September 15, 2021, IBX acquired life science company Roylance Pharma

Acquisition Highlights
  • This is IBX’s 1st transaction in the Life Science sector.
  • This is IBX’s 1st transaction in the United Kingdom.

M&A Deal Summary
Date 2021-09-15
Target Roylance Pharma
Sector Life Science
Buyer(s) IBX
Deal Type Add-on Acquisition

Target

Roylance Pharma

Macclesfield, United Kingdom
website
Roylance Pharma specialists in biobanking and stability storage of pharmaceutical and biological samples with a combined experience of over 50 years specifically in sample storage services. Processes have been built from the ground up with state-of-the-art facilities, validation, sops, and quality systems. Roylance Pharma is based in Macclesfield, United Kingdom.

Search 192,723 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

IBX

Piscataway, New Jersey, United States

website

Category Company
Sector Life Science
DESCRIPTION

IBX is biobanking, bioprocessing, and analytics company that provides global sample collection, processing, storage, and analytical services integrated with scientific and technical support in both the research and clinical arenas. IBX is based in Piscataway, New Jersey.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 1
Country (United Kingdom) 1 of 1
Year (2021) 1 of 1
Mergr

Product

Company

Legal